111 results on '"CoMSIA"'
Search Results
2. 3D-QSAR, Scaffold Hopping, Virtual Screening, and Molecular Dynamics Simulations of Pyridin-2-one as mIDH1 Inhibitors.
- Author
-
Wang, Yifan, Jia, Shunjiang, Wang, Fan, Jiang, Ruizhe, Yin, Xiaodan, Wang, Shuo, Jin, Ruyi, Guo, Hui, Tang, Yuping, and Wang, Yuwei
- Subjects
- *
MOLECULAR dynamics , *COMPARATIVE molecular field analysis , *KREBS cycle , *ISOCITRATE dehydrogenase , *RESPIRATION , *STRUCTURE-activity relationships - Abstract
Isocitrate dehydrogenase 1 (IDH1) is a necessary enzyme for cellular respiration in the tricarboxylic acid cycle. Mutant isocitrate dehydrogenase 1 (mIDH1) has been detected overexpressed in a variety of cancers. mIDH1 inhibitor ivosidenib (AG-120) was only approved by the Food and Drug Administration (FDA) for marketing, nevertheless, a range of resistance has been frequently reported. In this study, several mIDH1 inhibitors with the common backbone pyridin-2-one were explored using the three-dimensional structure–activity relationship (3D-QSAR), scaffold hopping, absorption, distribution, metabolism, excretion (ADME) prediction, and molecular dynamics (MD) simulations. Comparative molecular field analysis (CoMFA, R2 = 0.980, Q2 = 0.765) and comparative molecular similarity index analysis (CoMSIA, R2 = 0.997, Q2 = 0.770) were used to build 3D-QSAR models, which yielded notably decent predictive ability. A series of novel structures was designed through scaffold hopping. The predicted pIC50 values of C3, C6, and C9 were higher in the model of 3D-QSAR. Additionally, MD simulations culminated in the identification of potent mIDH1 inhibitors, exhibiting strong binding interactions, while the analyzed parameters were free energy landscape (FEL), radius of gyration (Rg), solvent accessible surface area (SASA), and polar surface area (PSA). Binding free energy demonstrated that C2 exhibited the highest binding free energy with IDH1, which was −93.25 ± 5.20 kcal/mol. This research offers theoretical guidance for the rational design of novel mIDH1 inhibitors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Exploring Structure–Toxicity Relationships in Nitrobenzene and Derivatives: A Multifaceted Biochemical Investigation Using 3D–QSPR, HQSPR, Molecular Docking, and MD Simulation.
- Author
-
Ouabane, Mohamed, Zaki, Khadija, Alaqarbeh, Marwa, Guendouzi, Abdelkrim, Sekkate, Chakib, Sbai, Abdelouahid, Bouachrine, Mohammed, and Lakhlifi, Tahar
- Subjects
- *
NITROBENZENE , *MOLECULAR docking , *PROTEIN-ligand interactions , *COMPUTATIONAL chemistry , *CHEMICAL derivatives - Abstract
Nitrobenzene derivatives present an environmental concern to aquatic organisms, as well as a potential adverse effects on human health due to their toxicity. Therefore, monitoring nitrobenzene contamination levels is critical to protect both the ecosystem and the public. This study aims to quantitatively correlate the toxicity of nitrobenzene derivatives to their chemical structures using computational chemistry methods such as 3D‐QSPR, HQSPR, Molecular Docking and MD simulation. Additionally, to investigate the type of interactions and stability of nitrobenzene derivatives with the PP2 protein involved in the Phloem protein 2 (PP2). From each computational method a prediction model was extracted HQSPR (Atomic, Bonds, Donor/Acceptor, 3D‐QSPR (Steric, Electrostatic, Hydrophobic, Acceptor), and used for the design of X1 and X2 new nitrobenzene derivatives, which showed remarkable stability and better interactions. This study contributes to the understanding of the nitrobenzene derivatives' toxicity and offers materials towards the understanding of the mechanism of action of these substances in protein–ligand interactions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Computational integration for antifungal 1,2,4-triazole inhibitors design: QSAR, molecular docking, molecular dynamics simulations, ADME/Tox, and retrosynthesis studies
- Author
-
Soukaina Bouamrane, Ayoub Khaldan, Marwa Alaqarbeh, Abdelouahid Sbai, Mohammed Aziz Ajana, Tahar Lakhlifi, Mohammed Bouachrine, and Hamid Maghat
- Subjects
CoMFA ,CoMSIA ,HQSAR ,Lipinski's rule ,Protein–ligand interaction ,Physics ,QC1-999 ,Chemistry ,QD1-999 - Abstract
Fungal infections are a growing public health problem worldwide. Despite the availability of several medicines, their efficacy is still constrained by fungal resistance. This research conducted the 2D/3D-QSAR analysis on twenty-nine triazole molecules previously evaluated for their antifungal activity. The HQSAR/B-H, CoMFA and CoMSIA models were built using twenty-three molecules in the training set. They show high Q2 values (0.646, 0.564 and 0.561, respectively) and important R2 values (0.764, 0.805 and 0.787, respectively). The predictive capacity of the established models was validated by external validation; they performed well. The contour maps derived from the HQSAR/B-H, CoMFA and CoMSIA models provide more detail to identify favorable and unfavorable groupings impacting the activity. Then, 4 proposed new triazole molecules with significant antifungal activity were suggested. In addition, the molecular docking results showed good binding energies and interactions of the proposed inhibitors in the active site of the receptor studied. The molecular dynamics and MM/PBSA methods confirmed and validated the molecular docking results. The new triazole molecules were evaluated for their oral bioavailability and toxicity using ADME/Tox properties. Finally, the retrosynthesis method created a synthetic pathway for the candidate inhibitor Z1.
- Published
- 2024
- Full Text
- View/download PDF
5. Hybrid 2D/3D-quantitative structure–activity relationship studies on the bioactivities and molecular mechanism of antibacterial peptides.
- Author
-
Yan, Qingguo, Wang, Fangfang, Zhou, Bo, and Lin, Xiangna
- Abstract
Antimicrobial peptide (AMP) is the polypeptide, which protects the organism avoiding attack from pathogenic bacteria. Studies have shown that there were some antimicrobial peptides with molecular action mechanism involved in crossing the cell membrane without inducing severe membrane collapse, then interacting with cytoplasmic target-nucleic acid, and exerting antibacterial activity by interfacing the transmission of genetic information of pathogenic microorganisms. However, the relationship between the antibacterial activities and peptide structures was still unclear. Therefore, in the present work, a series of AMPs with a sequence of 20 amino acids was extracted from DBAASP database, then, quantitative structure–activity relationship (QSAR) methods were conducted on these peptides. In addition, novel antimicrobial peptides with stronger antimicrobial activities were designed according to the information originated from the constructed models. Hence, the outcome of this study would lay a solid foundation for the in-silico design and exploration of novel antibacterial peptides with improved activity activities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. QSAR Studies, Synthesis, and Biological Evaluation of New Pyrimido-Isoquinolin-Quinone Derivatives against Methicillin-Resistant Staphylococcus aureus.
- Author
-
Andrades-Lagos, Juan, Campanini-Salinas, Javier, Sabadini, Gianfranco, Andrade, Victor, Mella, Jaime, and Vásquez-Velásquez, David
- Subjects
- *
DRUG resistance in microorganisms , *ANTIBACTERIAL agents , *COMPARATIVE molecular field analysis , *CHEMICAL synthesis , *DRUG discovery - Abstract
According to the WHO, antimicrobial resistance is among the top 10 threats to global health. Due to increased resistance rates, an increase in the mortality and morbidity of patients has been observed, with projections of more than 10 million deaths associated with infections caused by antibacterial resistant microorganisms. Our research group has developed a new family of pyrimido-isoquinolin-quinones showing antibacterial activities against multidrug-resistant Staphylococcus aureus. We have developed 3D-QSAR CoMFA and CoMSIA studies (r2 = 0.938; 0.895), from which 13 new derivatives were designed and synthesized. The compounds were tested in antibacterial assays against methicillin-resistant Staphylococcus aureus and other bacterial pathogens. There were 12 synthesized compounds active against Gram-positive pathogens in concentrations ranging from 2 to 32 µg/mL. The antibacterial activity of the derivatives is explained by the steric, electronic, and hydrogen-bond acceptor properties of the compounds. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. 3D-QSAR, Scaffold Hopping, Virtual Screening, and Molecular Dynamics Simulations of Pyridin-2-one as mIDH1 Inhibitors
- Author
-
Yifan Wang, Shunjiang Jia, Fan Wang, Ruizhe Jiang, Xiaodan Yin, Shuo Wang, Ruyi Jin, Hui Guo, Yuping Tang, and Yuwei Wang
- Subjects
IDH1 ,CoMFA ,CoMSIA ,scaffold hopping ,molecular dynamics simulations ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Isocitrate dehydrogenase 1 (IDH1) is a necessary enzyme for cellular respiration in the tricarboxylic acid cycle. Mutant isocitrate dehydrogenase 1 (mIDH1) has been detected overexpressed in a variety of cancers. mIDH1 inhibitor ivosidenib (AG-120) was only approved by the Food and Drug Administration (FDA) for marketing, nevertheless, a range of resistance has been frequently reported. In this study, several mIDH1 inhibitors with the common backbone pyridin-2-one were explored using the three-dimensional structure–activity relationship (3D-QSAR), scaffold hopping, absorption, distribution, metabolism, excretion (ADME) prediction, and molecular dynamics (MD) simulations. Comparative molecular field analysis (CoMFA, R2 = 0.980, Q2 = 0.765) and comparative molecular similarity index analysis (CoMSIA, R2 = 0.997, Q2 = 0.770) were used to build 3D-QSAR models, which yielded notably decent predictive ability. A series of novel structures was designed through scaffold hopping. The predicted pIC50 values of C3, C6, and C9 were higher in the model of 3D-QSAR. Additionally, MD simulations culminated in the identification of potent mIDH1 inhibitors, exhibiting strong binding interactions, while the analyzed parameters were free energy landscape (FEL), radius of gyration (Rg), solvent accessible surface area (SASA), and polar surface area (PSA). Binding free energy demonstrated that C2 exhibited the highest binding free energy with IDH1, which was −93.25 ± 5.20 kcal/mol. This research offers theoretical guidance for the rational design of novel mIDH1 inhibitors.
- Published
- 2024
- Full Text
- View/download PDF
8. Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches.
- Author
-
Baidya, S.K., Banerjee, S., Ghosh, B., Jha, T., and Adhikari, N.
- Subjects
- *
ANTINEOPLASTIC agents , *AMINO acid residues , *HYDROGEN bonding interactions , *SPATIAL orientation , *HYDROGEN bonding , *MALTODEXTRIN , *GLUTAMINE synthetase , *GLUTAMINE - Abstract
MMP-2 is potentially contributing to several cancer progressions including leukaemias. Therefore, considering MMP-2 as a promising target, novel anticancer compounds may be designed. Here, 32 in-house arylsulfonyl L-(+) glutamines were subjected to various structure-based computational modelling approaches to recognize crucial structural attributes along with the spatial orientation for higher MMP-2 inhibition. Again, the docking-based 2D-QSAR study revealed that the Coulomb energy conferred by Tyr142 and total interaction energy conferred by Ala84 was crucial for MMP-2 inhibition. Importantly, the docking-dependent CoMFA and CoMSIA study revealed the importance of favourable steric, electrostatic, and hydrophobic substituents at the terminal phenyl ring. The MD simulation study revealed a lower fluctuation in the RMSD, RMSF, and Rg values indicating stable binding interactions of MMP-2 and these molecules. Moreover, the residual hydrogen bond and their interaction analysis disclosed crucial amino acid residues responsible for forming potential hydrogen bonding for higher MMP-2 inhibition. The results can effectively aid in the design and discovery of promising small-molecule drug-like MMP-2 inhibitors with greater anticancer potential in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. 3D-QSAR-based design, synthesis and biological evaluation of 2,4-disubstituted quinoline derivatives as antimalarial agents.
- Author
-
Vyas, V.K., Bhati, S., Sharma, M., Gehlot, P., Patel, N., and Dalai, S.
- Subjects
- *
BIOSYNTHESIS , *ANTIMALARIALS , *SECONDARY amines , *COMPARATIVE molecular field analysis , *QUINOLINE derivatives , *QUINOLINE - Abstract
2,4-Disubstituted quinoline derivatives were designed based on a 3D-QSAR study, synthesized and evaluated for antimalarial activity. A large dataset of 178 quinoline derivatives was used to perform a 3D-QSAR study using CoMFA and CoMSIA models. PLS analysis provided statistically validated results for CoMFA (r2ncv = 0.969, q2 = 0.677, r2cv = 0.682) and CoMSIA (r2ncv = 0.962, q2 = 0.741, r2cv = 0.683) models. Two series of a total of 40 2,4-disubstituted quinoline derivatives were designed with amide (quinoline-4-carboxamide) and secondary amine (4-aminoquinoline) linkers at the -C4 position of the quinoline ring. For the purpose of selecting better compounds for synthesis with good pEC50 values, activity prediction was carried out using CoMFA and CoMSIA models. Finally, a total of 10 2,4-disubstituted quinoline derivatives were synthesized, and screened for their antimalarial activity based on the reduction of parasitaemia. Compound #5 with amide linker and compound #19 with secondary amine linkers at the -C4 position of the quinoline ring showed maximum reductions of 64% and 57%, respectively, in the level of parasitaemia. In vivo screening assay confirmed and validated the findings of the 3D-QSAR study for the design of quinoline derivatives. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Computational Investigation of Isoxazole‐Based Molecules as Potential Drug‐Resistant Anti‐Tuberculosis H37Rv.
- Author
-
Moukhliss, Youness, Koubi, Yassine, Alaqarbeh, Marwa, Maghat, Hamid, Sbai, Abdelouahid, Bouachrine, Mohammed, and Lakhlifi, Tahar
- Subjects
- *
MYCOBACTERIUM tuberculosis , *MOLECULAR models , *MOLECULES , *MOLECULAR dynamics , *ISONIAZID - Abstract
Investigation of new active therapeutic drugs against the emerging drug‐resistant Mycobacterium tuberculosis is a current medical and health challenge. Based on previously reported isoxazole‐based molecules that have a potent effect against Mycobacterium tuberculosis, computational methods were used in the current study to investigate the effect of isoxazole‐based molecules as a potential active drug‐resistant drug Mycobacterium tuberculosis H37Rv. Molecular models of isoxazole‐based molecules were established by 3D‐QSAR study, and different results were interpreted to propose 6 candidate agents more active than the previously reported compounds in the literature. Also, the candidate structures are more active than the therapeutic drug agent Isoniazid (NIH) against Mycobacterium Tuberculosis. Evaluation of the synthetic accessibility coefficient and the Lipinski properties of newly designed agent candidates indicate that these agents meet the criteria of a drug according to the Lipinski and Veber rules because they can be synthesized. In‐silico evaluation of ADMETox properties shows satisfactory results for most newly designed agent candidates. According to molecular docking, the drug candidates have a high score with a stable docked pose in the receptor (PDB code: 5v3y) compared to Isoniazid (NIH). The DFT and molecular dynamics study confirmed the previous results of 3D‐QSAR and molecular docking models. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. 3D quantitative structure–activity relationships study on anti-gastric cancer of chrysin derivatives.
- Author
-
Liu, Yunmei, Tian, Zejie, Li, Hui, Liu, Zhenhua, Shi, Lei, and Yang, Lingyan
- Subjects
- *
STRUCTURE-activity relationships , *COMPARATIVE molecular field analysis , *MOLECULAR orientation , *DOSAGE forms of drugs , *HYDROGEN bonding - Abstract
In this paper, 3D-QSAR models were constructed to conduct a preliminary study on the structure–activity relationship of chrysin. The three-dimensional structures of the selected 54 chrysin derivatives were constructed by SYBYL-X 2.0 software, molecular mechanics procedures for conformational optimization, and molecular alignment. The 3D-QSAR model of these compounds was constructed by comparative molecular force field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA), and the structure–activity relationships of chrysin compounds was preliminarily discussed. CoMFA and CoMSIA models are all constructed reasonably and reliably (CoMFA: q2 = 0.703, r2 = 0.886, SEE = 0.217, F = 113.572; CoMSIA: q2 = 0.647, r2 = 0.841, SEE = 0.255, F = 111.740), a series of three-dimensional contour maps were obtained to visualize the influence of various fields around the compound molecules on the drug activity. Groups with more hydrogen bonding acceptors attached to the end of the 7-O-alkane chain of chrysin are favorable for the molecular activity, such as amino acids. However, excessively long 7-O-alkane chains or the introduction of bulky hydrophobic groups on the 7-O-alkane chain will reduce the activity of the molecule. In contrast, the introduction of bulky hydrophobic groups on the side chains of amino acids will enhance the molecular activity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Design of benzimidazoles, benzoxazoles, benzothiazoles and thiazolopyridines as leukotriene A4 hydrolase inhibitors through 3D-QSAR, docking and molecular dynamics
- Author
-
Lorca Marcos, Faúndez Mario, Pessoa-Mahana David C., Recabarren-Gajardo Gonzalo, Diethelm-Varela Benjamin, Millán Daniela, Celik Ismail, Mellado Marco, Araque Ileana, Mella Jaime, and Romero-Parra Javier
- Subjects
comfa ,comsia ,binding free energy calculation ,cadd ,inflamemation ,allergy ,Chemistry ,QD1-999 - Abstract
Human leukotriene A4 hydrolase enzyme (LTA4H) catalyses the biotransformation of the inactive precursor leukotriene A4 (LTA4) to the bioactive Leukotriene B4 (LTB4), which causes many inflammatory responses in the human body. Therefore, the selective inhibition of this enzyme becomes a useful strategy for the treatment of several illnesses such as asthma, allergic rhinitis, cardiovascular diseases, and cancer. Herein we report a 3D-QSAR/ /CoMFA and CoMSIA study on a series of 47 benzimidazoles, benzoxazoles, benzothiazoles and thiazolopyridines reported as potent LTA4H inhibitors. Good statistical parameters were obtained for the best model (q2 = 0.568, r2 ncv = 0.891 and r2 test = 0.851). A new series of 10 compounds capable of inhibiting leukotriene A4 hydrolase with high potency was presented. All designed inhibitors showed low IC50 in nano- and sub-nanomolar ranges, when they were evaluated in 3D-QSAR models. Subsequently, the designed molecules, as well as the least and most active compounds were subjected to docking and molecular dynamics studies into LTA4H. In conclusion, we summarised a thorough structure–activity relationship (SAR) of LTA4H inhibitors of heterocyclic structure. These models can be used for the rational proposal of new inhibitors.
- Published
- 2023
- Full Text
- View/download PDF
13. Structural Insights on Hyp-Gly-Containing Peptides as Antiplatelet Compounds through Topomer CoMFA and CoMSIA Analysis.
- Author
-
Yang, Yijie, Tian, Qi, Li, Shiming, and Li, Bo
- Subjects
COMPARATIVE molecular field analysis ,PEPTIDES ,STRUCTURE-activity relationships ,SILVER carp ,QSAR models ,ADENOSINE diphosphate - Abstract
Increasing evidence has shown collagen hydrolysate involves a variety of bioactivities. In our previous study, multiple antiplatelet peptides containing Hyp/Pro-Gly were identified in collagen hydrolysates from Salmo salar and silver carp skin and exhibited anti-thrombosis activity without bleeding risks in vivo. However, the relationship between structure and activity remains unknown. We performed 3D-QSAR studies on 23 Hyp/Pro-Gly-containing peptides in which 13 peptides were reported before. CoMFA, Topomer CoMFA and CoMSIA analyses were used to generate the QSAR models. Topomer CoMFA analysis showed a q
2 value of 0.710, an r2 value of 0.826, an r2 pred value of 0.930, and the results showed that Hyp instead of Pro was more important for improving the antiplatelet activity. CoMSIA analysis showed a q2 value of 0.461, an r2 value of 0.999, and an r2 pred value of 0.999. Compared with the electrostatic field and hydrogen bond donor field, the steric field, hydrophobic field and hydrogen bond receptor field have great influence on the activity of antiplatelet peptides. The predicted peptide EOGE exhibited antiplatelet activity induced by ADP, and inhibited thrombus formation (300 μmol/kg bw) without bleeding risks. Combined results of these studies indicate that OG-containing peptides had a potential to be developed into an effective specific medical food in the prevention of thrombotic diseases. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
14. 3d qsar analysis of flavones as antidiabetic agents
- Author
-
Sainy, Navin, Dubey, Nidhi, Sharma, Rajesh, Dubey, Nitin, and Sainy, Jitendra
- Published
- 2022
- Full Text
- View/download PDF
15. A comparative quantitative structural assessment of benzothiazine-derived HDAC8 inhibitors by predictive ligand-based drug designing approaches.
- Author
-
Banerjee, S., Baidya, S.K., Adhikari, N., and Jha, T.
- Subjects
- *
DRUG design , *HISTONE deacetylase , *HISTONE deacetylase inhibitors , *MOLECULAR docking , *STRUCTURAL components - Abstract
Histone deacetylase 8 (HDAC8) is a verified biomolecular target associated with diverse diseases including cancer. Though several HDAC inhibitors emerged effective against such diseases, no selective HDAC8 inhibitor is approved to date. Therefore, the development of potent HDAC8-selective inhibitors is inevitable to combat such diseases. Here, some benzothiazine-derived HDAC8 inhibitors were considered for a comparative QSAR analysis which may elucidate the prime structural components responsible for modulating their efficacy. Several outcomes from these diverse modelling techniques justified one another and thus validated each other. The ligand-based pharmacophore modelling study identified ring aromatic, positive ionizable, and hydrophobic features as essential structural attributes for HDAC8 inhibition. Besides, MLR, HQSAR and field-based 3D-QSAR studies signified the utility of the positive ionizable and hydrophobic features for potent HDAC8 inhibition. Again, the field-based 3D-QSAR study provided useful insight regarding the substitution in the fused phenyl ring. Moreover, the current observations also validated the previously reported molecular docking observations. Based on the outcomes, some new molecules were designed and predicted. Therefore, this comparative structural analysis of these HDAC8 inhibitors will surely assist in the development of potent HDAC8 inhibitors as promising anticancer therapeutics in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. 3D-QSAR and molecular docking studies of aminothiazole derivatives as Lim kinase 1 inhibitors.
- Author
-
JING-XUAN HOU, QING-SHAN GU, MEI-QI SHI, HUI GAO, LU ZHENG, and QING-KUN WU
- Subjects
- *
MOLECULAR docking , *THIAZOLES , *KINASE inhibitors , *PROTEIN receptors , *COMPARATIVE molecular field analysis , *METASTASIS - Abstract
Lim kinase (Limk), as an important cytoskeletal regulator, plays an important role in cancer manifestations and neuronal diseases. Limk1 is a member of the Limk family, which is mainly involved in the invasion and metastasis of tumor cells and is abnormally expressed in a variety of cell carcinoma tissues. In this paper, a series of Limk1 inhibitors with aminothiazole skeleton were used to design potent and efficient Limk1 inhibitors by computational approaches. Firstly, the 3D-QSAR model was constructed, and both CoMFA and CoMSIA models have good correlation and prediction ability. The binding requirements between ligand and receptor protein were then further explored through molecular docking, including the critical forces between Limk1 inhibitors and active site residues. Finally, based on the 3D-QSAR model and molecular docking results analysis, three new compounds with theoretically better activity were designed and their ADME properties were predicted. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. Comparative binding affinity analysis of dual CDK2/FLT3 inhibitors.
- Author
-
Ghosh, Suparna and Cho, Seung Joo
- Subjects
- *
PROTEIN-tyrosine kinases , *ACUTE myeloid leukemia , *CYCLIN-dependent kinases , *SMALL molecules , *QUINOLINE derivatives , *LIGAND binding (Biochemistry) - Abstract
Selective inhibition of cyclin‐dependent kinase 2 (CDK2) using small molecules is gaining popularity for the treatment of certain types of acute myeloid leukemia (AML). In this study, we used different molecular modeling techniques to investigate the structure–activity relationship (SAR) and binding modalities of dual CDK2/FLT3 inhibitors. The key chemical characteristics of the 3H‐pyrazolo[4,3‐f]quinoline derivatives were highlighted as descriptive colored contours using comparative molecular similarity analysis (CoMSIA). Modifying chemical groups in existing compounds along these contours could improve CDK2 selectivity over FMS‐like tyrosine kinase 3 (FLT3). We determined the ligand affinities for CDK2 by estimating the binding free energy using molecular mechanics generalized Born surface area (MM‐GBSA) and umbrella sampling (US) simulations. Reasonable correlations were found between the computed and experimental binding energies, suggesting that MM‐GBSA and US can be used to reliably predict the binding affinities of new compounds in the more potent CDK2 drug development process. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Insight into the structural requirements of antimicrobial peptides by multiple validated 3D-QSAR approaches.
- Author
-
Wang, Fangfang, Zhang, Ke, and Zhou, Bo
- Subjects
- *
ANTIMICROBIAL peptides , *COMPARATIVE molecular field analysis , *PEPTIDE antibiotics , *CATHELICIDINS , *STRUCTURE-activity relationships , *PEPTIDES - Abstract
Antibacterial peptides (AMPs) are a kind of peptide material produced by the organism to resist the invasion of exogenous pathogens. Several antimicrobial peptides in different structures have been reported. To elucidate the relationship between structure and activity. A molecular modelling study on the nonapeptides using three-dimensional quantitative structure–activity relationship (3D-QSAR) was carried out. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) methods were employed for the identification of significant features of antimicrobial peptides. CoMFA and CoMSIA models all gave best parametric results ( R cv 2 = 0.563, R pred 2 = 0.654 for CoMFA; R cv 2 = 0.656, R pred 2 = 0.8045 for CoMSIA), which suggested that the derived models are highly robust and predictive. In addition, the derived contour maps would provide structural features to improve binding activity, and indicated that steric, electrostatic, and hydrophobic fields play vital roles in improving the activity. The derived models and information may help to provide an insight into the structural requirements for more potent peptides and facilitate the design and optimisation of novel antimicrobial peptides with promising enhanced activity. Furthermore, some potential candidate antimicrobial peptides have been proposed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. Structure-Activity Relationship Studies Based on 3D-QSAR CoMFA/CoMSIA for Thieno-Pyrimidine Derivatives as Triple Negative Breast Cancer Inhibitors.
- Author
-
Kim, Jin-Hee and Jeong, Jin-Hyun
- Subjects
- *
TRIPLE-negative breast cancer , *PYRIMIDINES , *STRUCTURE-activity relationships , *METASTATIC breast cancer , *COMPARATIVE molecular field analysis , *PROGESTERONE receptors , *EPIDERMAL growth factor receptors - Abstract
Triple-negative breast cancer (TNBC) is defined as a kind of breast cancer that lacks estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptors (HER2). This cancer accounts for 10–15% of all breast cancers and has the features of high invasiveness and metastatic potential. The treatment regimens are still lacking and need to develop novel inhibitors for therapeutic strategies. Three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses, based on a series of forty-seven thieno-pyrimidine derivatives, were performed to identify the key structural features for the inhibitory biological activities. The established comparative molecular field analysis (CoMFA) presented a leave-one-out cross-validated correlation coefficient q2 of 0.818 and a determination coefficient r2 of 0.917. In comparative molecular similarity indices analysis (CoMSIA), a q2 of 0.801 and an r2 of 0.897 were exhibited. The predictive capability of these models was confirmed by using external validation and was further validated by the progressive scrambling stability test. From these results of validation, the models were determined to be statistically reliable and robust. This study could provide valuable information for further optimization and design of novel inhibitors against metastatic breast cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Novel dihydropyrimidines as promising EGFR & HER2 inhibitors: Insights from experimental and computational studies.
- Author
-
Faizan, Syed, Wali, Adil Farooq, Talath, Sirajunisa, Rehman, Muneeb U., Sivamani, Yuvaraj, Nilugal, Kiran C., Shivangere, Narendra Babu, Attia, Sabry M., Nadeem, Ahmed, Elayaperumal, Sumitha, and Kumar, B.R. Prashantha
- Subjects
- *
STRUCTURE-activity relationships , *EPIDERMAL growth factor receptors , *CYTOTOXINS , *BREAST cancer , *MOLECULAR docking - Abstract
Dihydropyrimidines are widely recognized for their diverse biological properties and are often synthesized by the Biginelli reactions. In this backdrop, a novel series of Biginelli dihydropyrimidines were designed, synthesized, purified, and analyzed by FT-IR, 1H NMR, 13C NMR, and mass spectrometry. Anticancer activity against MCF-7 breast cancer cells was evaluated as part of their cytotoxicity in comparison with the normal Vero cells. The cytotoxicity of dihydropyrimidines ranges from moderate to significant. Among the 38 dihydropyrimidines screened, compounds 16 , 21 , and 39 exhibited significant cytotoxicity. These 3 compounds were subjected to flow cytometry studies and EGFRwt Kinase inhibition assay using lapatinib as a standard. The study included evaluation for the inhibition of EGFR and HER2 expression at five different concentrations. At a concentration of 1000 nM compound 21 showed 98.51 % and 96.79 % inhibition of EGFR and HER2 expression. Moreover, compounds 16 , 21 and 39 significantly inhibited EGFRwt activity with IC 50 = 69.83, 37.21 and 76.79 nM, respectively. In addition, 3D-QSAR experiments were conducted to elucidate Structure activity relationships in a 3D grid space by comparing the experimental and predicted cytotoxic activities. Molecular docking studies were performed to validate the results by in silico method. All together, we developed a new series of Biginelli dihydropyrimidines as dual EGFR/HER2 inhibitors. [Display omitted] • Multicomponent reactions help to swiftly synthesize and evaluate molecules for activity. • This research covers synthesis of 38 dihydropyrimidines and their activity against EGFR/HER2. • Novel dihydropyrimidines can be potential anticancer therapeutics. • Synthesized dihydropyrimidines are quite effective against breast cancer target. • Computational studies have been performed as predictive analysis to correlate with experimental studies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. 3D-QSAR and molecular docking studies of aminothiazole derivatives as Lim kinase 1 inhibitors
- Author
-
Hou Jing-Xuan, Gu Qing-Shan, Shi Mei-Qi, Gao Hui, Lu Zheng, and Wu Qing-Kun
- Subjects
cancer ,comfa ,comsia ,computational drug design ,Chemistry ,QD1-999 - Abstract
Lim kinase (Limk), as an important cytoskeletal regulator, plays an important role in cancer manifestations and neuronal diseases. Limk1 is a member of the Limk family, which is mainly involved in the invasion and metastasis of tumor cells and is abnormally expressed in a variety of cell carcinoma tissues. In this paper, a series of Limk1 inhibitors with aminothiazole skeleton were used to design potent and efficient Limk1 inhibitors by computational approaches. Firstly, the 3D-QSAR model was constructed, and both CoMFA and CoMSIA models have good correlation and prediction ability. The binding requirements between ligand and receptor protein were then further explored through molecular docking, including the critical forces between Limk1 inhibitors and active site residues. Finally, based on the 3D-QSAR model and molecular docking results analysis, three new compounds with theoretically better activity were designed and their ADME properties were predicted.
- Published
- 2022
- Full Text
- View/download PDF
22. 3D-QSAR analysis of the interactions of flavonoids with human organic cation transporter 2.
- Author
-
Bi, Yajuan, Wang, Xue, Li, Huixiang, Tian, Yiqing, Han, Lifeng, Gui, Chunshan, and Zhang, Youcai
- Subjects
- *
ORGANIC cation transporters , *FLAVONOIDS , *SOCIAL interaction , *DRUG interactions , *URONIC acids , *COMPARATIVE molecular field analysis - Abstract
Flavonoids are a class of phenolic and polyphenolic compounds widely distributed in vegetables, fruits, grains and herbs. Organic cation transporter 2 (OCT2) mediates the renal secretion of organic cations and is a key site of drug-drug interactions (DDIs). In this study, we systematically investigated the inhibitory effect of 28 flavonoids on OCT2-mediated uptake of 4–4-dimethylaminostyryl-N-methylpyridinium (ASP+). Among them, scullcapflavone II demonstrated the strongest inhibitory effect on OCT2-mediated uptake of ASP+ (IC 50 =11.2 μM) in a competitive manner. Next, 3D-QSAR analyses of flavonoid OCT2 inhibitors were performed using both CoMFA and CoMSIA models. The date revealed that bulky substituents at the C-3 and C-4 positions of ring C as well as the C-7 position of ring A could prevent the interactions of flavonoids with OCT2. In contrast, a hydrophilic and negatively charge substituent on ring A was favorable for the interactions of flavonoids with OCT2. Consequently, baicalin (IC 50 =220.2 μM) with a uronic acid substituent on ring A exhibited a stronger inhibition than baicalein (IC 50 =294.5 μM); quercetin-3-O-galactoside (IC 50 =497.4 μM) was a stronger inhibitor of OCT2 than rhamnetin 3-galactoside (IC 50 =1409.0 μM). Taken together, our findings could be valuable in elucidating and predicting the interactions of flavonoids with OCT2. [Display omitted] • Inhibitory effects of 28 flavonoids on OCT2 were investigated. • CoMFA and CoMSIA models were developed for flavonoids as OCT2 inhibitors. • Bulky substituents at C-3, C-4 positions of ring C or C-7 position of ring A were important. • Hydrophilicity of ring A contributes to the interactions of flavonoids with OCT2. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
23. Molecular Docking and Three‐Dimensional Quantitative Structure–Activity Relationships for Antitubercular Pyrimidine Derivatives.
- Author
-
Parkali, Praveen M., Shyam Kumar, A., Johanna K, Pohamba, Prodensia T, Shilomboleni, Turaga, Sruthi, Shaiva, Vinod, Pujar, Gurubasavaraj V., Joshi, Shrinivas D., Aminabhavi, Tejraj M., and Dixit, Sheshagiri R.
- Subjects
- *
MOLECULAR docking , *PYRIMIDINE derivatives , *STRUCTURE-activity relationships , *ACYL carrier protein , *AMINO acid residues , *PYRIMIDINES - Abstract
Enoyl Acyl Carrier Protein (ACP) Reductase, a key enzyme, which catalyzes the last reductive step of fatty acid biosynthesis and it, is one of the key enzymes for the development of antitubercular agents. In this pursuit, molecular docking and 3D-QSAR studies (CoMFA and CoMSIA) have been performed on a series of pyrimidine derivatives (29 compounds) to understand the binding sites, interactions to improve over the existing leads in terms of improved biological and physico-chemical properties. Molecular docking was performed on a protein InhA (T2A mutant) (PDB ID: 5OIR) using the Surflex-Dock suite available in SYBYL-X 2.1.1 (Tripose Inc., USA). In addition, 3D-QSAR studies have been performed to validate the models using the data set, which was segregated into training and test set by using the Diversity and Dissimilarity method. Structural features required for the prediction of better inhibitory potency was generated in the form of contour maps from the CoMFA and CoMSIA models (Steric, Electrostatic, Hydrophobicity, H-bond donor and acceptor maps) and predicted values for r2 = 0.966, q2 = 0.22 for the CoMFA model and r2 = 0.925, q2 = 0.576 for the CoMSIA model. From this study, it is observed that interaction with amino acid residues TYR158, MET199, MET161, GLY96, and PHE97 are important for the activity that helped to predict SARs by providing important structural features. Both the models were good in understanding the specific activity of some of the compounds that will facilitate to develop new types of Enoyl ACP reductase inhibitors. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
24. In silico research on new sulfonamide derivatives as BRD4 inhibitors targeting acute myeloid leukemia using various computational techniques including 3D-QSAR, HQSAR, molecular docking, ADME/Tox, and molecular dynamics.
- Author
-
Belghalia E, Ouabane M, El Bahi S, Rehman HM, Sbai A, Lakhlifi T, and Bouachrine M
- Subjects
- Humans, Protein Binding, Hydrogen Bonding, Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology, Hydrophobic and Hydrophilic Interactions, Binding Sites, Nuclear Proteins antagonists & inhibitors, Nuclear Proteins chemistry, Nuclear Proteins metabolism, Computer Simulation, Bromodomain Containing Proteins, Quantitative Structure-Activity Relationship, Molecular Dynamics Simulation, Molecular Docking Simulation, Transcription Factors antagonists & inhibitors, Transcription Factors chemistry, Transcription Factors metabolism, Leukemia, Myeloid, Acute drug therapy, Sulfonamides chemistry, Sulfonamides pharmacology, Cell Cycle Proteins antagonists & inhibitors, Cell Cycle Proteins chemistry, Cell Cycle Proteins metabolism
- Abstract
Acute myeloid leukemia, a serious condition affecting stem cells, drives uncontrollable myeloblast proliferation, leading to accumulation. Extensive research seeks rapid, effective chemotherapeutics. A potential option is a BRD4 inhibitor, known for suppressing cell proliferation. Sulfonamide derivatives probed essential structural elements for potent BRD4 inhibitors. To achieve this goal, we employed 3D-QSAR molecular modeling techniques, including CoMFA, CoMSIA, and HQSAR models, along with molecular docking and molecular dynamics simulations. The validation of the 2D/3D QSAR models, both internally and externally, underscores their robustness and reliability. The contour plots derived from CoMFA, CoMSIA, and HQSAR analyses played a pivotal role in shaping the design of effective BRD4 inhibitors. Importantly, our findings highlight the advantageous impact of incorporating bulkier substituents on the pyridinone ring and hydrophobic/electrostatic substituents on the methoxy-substituted phenyl ring, enhancing interactions with the BRD4 target. The interaction mode of the new compounds with the BRD4 receptor (PDB ID: 4BJX) was investigated using molecular docking simulations, revealing favorable binding energies, supported by the formation of hydrogen and hydrophobic bonds with key protein residues. Moreover, these novel inhibitors exhibited good oral bioavailability and demonstrated non-toxic properties based on ADMET analysis. Furthermore, the newly designed compounds along with the most active one from series 58, underwent a molecular dynamics simulation to analyze their behavior. The simulation provided additional evidence to support the molecular docking results, confirming the sustained stability of the analyzed molecules over the trajectory. This outcome could serve as a valuable reference for designing and developing novel and effective BRD4 inhibitors.Communicated by Ramaswamy H. Sarma.
- Published
- 2024
- Full Text
- View/download PDF
25. 3D-QSAR, ADMET, and molecular docking studies of aztreonam analogs as E. colis inhibitors.
- Author
-
Mitku ML, Simegn W, Chanie GS, Mohammed Seid A, Beyna AT, Kebad Mengesha A, Melese M, Esubalew D, Gela YY, Ayenew W, and Limenh LW
- Abstract
Background: The development of multidrug resistant strains of extended-spectrum β-lactamase-producing Escherichia coli has become a global problem; therefore, the discovery of new antibacterial agents is the only available solution., Objective: To improve and propose new compounds with antibacterial activity, the three-dimensional quantitative structure-activity relationship and molecular docking studies were carried out on Aztreonam analogs as E. coli inhibitors in DNA gyrase B., Method: This study's 3D-Quantitative structure-activity relationship model was created using on the Comparative Molecular Field Analysis and the Comparative Molecular Similarity Indices Analysis. Using the Comparative Molecular Field Analysis ( Q
2 = 0.73; R2 = 0.82), excellent predictability was achieved, and the best Comparative Molecular Similarity Indices Analysis model ( Q2 = 0.88; R2 = 0.9). The generated model's ability to predict outcomes was assessed through external validation using a test set compound and an applicability domain technique. In this study, the steric, electrostatic, and hydrogen bond acceptor fields played a key role in antibacterial activity., Results: The results of the molecular docking revealed that the newly generated compound A6 has the highest binding affinity with DNA gyrase B. It forms 10 hydrogen bonds with amino acid residues of Asn104, Asn274, Asn132, Ser70, Ser237, Thr105, Glu273, and 2 salt bridges with amino acid residues of Ser70 and Glu273 and one pi-pi interacting with Gys271 amino acid residue in the binding site of 5G1, and this result was validated by a new assessment method. We created some novel, highly effective DNA gyrase B inhibitors based on the earlier findings, and the most accurate model predicted their inhibitory actions. The ADMET characteristics and pharmacological similarity of these novel inhibitors were also examined., Conclusion: These findings would be very beneficial in guiding the optimization process for the identification of novel drugs that can address the issue of multiple drug resistance., Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2024.)- Published
- 2024
- Full Text
- View/download PDF
26. 3D-QSAR and Docking Studies on Pyrimidine Derivatives of Second-Generation ALK Inhibitors
- Author
-
Gang-Long Jiang, Lian-Hua Song, Yong-Fu Qiu, and Yu Liu
- Subjects
3d-qsar ,docking ,second-generation alk inhibitors ,comfa ,comsia ,Pharmacy and materia medica ,RS1-441 - Abstract
Anaplastic lymphoma kinase (ALK) is a promising target for the treatment of non-small cell lung cancer. Under crizotinib treatment, drug resistance and progressive disease appeared after the point mutations arising in the kinase domain of ALK. Second-generation ALK inhibitors can solve the deficiencies of the first generation, especially the drug resistance in cancer chemotherapy. Ceritinib (LDK378), a pyrimidine derivative, for example, can inhibit the activity of ALK with an IC50 value of 40.7 nmol/L, and can experience disease progression after initial treatment with crizotinib. Unfortunately, clear structure–activity relationships have not been identified to date, impeding the rational design of future compounds possessing ALK inhibition activity. To explore interesting insights into the structures of pyrimidine derivatives that influence the activities of the second-generation ALK inhibitors, three-dimensional quantitative structure–activity relationship (3D-QSAR) and molecular docking were performed on a total of 45 derivatives of pyrimidine. Comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA) techniques were used to generate 3D-QSAR models. CoMFA and CoMSIA were performed using the Sybyl X 2.0 package. Molecular docking analysis was performed using the Surflex-Dock module in SYBYL-X 2.0 package. We found in the CoMFA model that the non-cross-validated r2 value was 0.998, the cross-validated q 2 value was 0.663, and the F statistic value was 2,401.970, while the r2 value was 0.988; q 2 value was 0.730, and F value was 542.933 in CoMSIA models, suggesting the good predictability of the CoMFA and CoMSIA models. 3D contour maps and docking results suggested that different groups on the core parts of the compounds could enhance the biological activities. Based on these results, the established 3D-QSAR models and the binding structures of ALK inhibitors obtained favor the prediction of the activity of new inhibitors and will be helpful in the reasonable design of ALK inhibitors in the future.
- Published
- 2022
- Full Text
- View/download PDF
27. Molecular Docking and 3D-QSAR Studies on a Series of Benzenesulfonamide Derivatives as a Hepatitis B Virus Capsid Assembly Inhibitor.
- Author
-
Ma, Chao, Liu, Wen-guang, Liu, Wen-ding, Xi, Chang-cheng, Xiong, Fei, and Zhang, Shu-ping
- Subjects
- *
MOLECULAR docking , *HEPATITIS B virus , *QSAR models , *CAPSIDS , *STRUCTURE-activity relationships , *COMPARATIVE molecular field analysis - Abstract
In this paper, a three-dimensional quantitative structure-activity relationship (3D-QSAR) namely CoMFA and CoMSIA has been carried out on a series (43 compounds) of capsid assembly inhibitors on N-phenyl-3-sulfamoyl-benzamide-based. The statistical parameters from the models (CoMFA: r2 = 0.998, q2 = 0.625, r2pred = 0.837; CoMSIA: r2 = 0.987, q2 = 0.645, r2pred = 0.698) indicate that the data are well fitted and have high predictive ability. Molecular docking was employed to explore the binding mode between these compounds and the receptor protein, as well as help understand the structure-activity relationship revealed by CoMFA and CoMSIA. Contour maps of the QSAR models were generated and validated by molecular docking study. The final models of CoMFA/CoMSIA and molecular docking could be useful for the design and development of novel potent HBV capsid assembly inhibitors. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
28. Studies on the antibacterial activities and molecular mechanism of GyrB inhibitors by 3D-QSAR, molecular docking and molecular dynamics simulation
- Author
-
Fangfang Wang, Wei Yang, and Bo Zhou
- Subjects
GyrB ,CoMFA ,CoMSIA ,Molecular docking ,Molecular dynamics ,Chemistry ,QD1-999 - Abstract
DNA gyrase B (GyrB) plays a critical role in DNA replication, repair, recombination, and transcription and has become an attractive target for a number of antibacterial agents. In the present work, to better comprehend the structure–activity relationship and mechanism of action of novel series of GyrB inhibitors, a theoretical study of three-dimensional-quantitative structure–activity relationship (3D-QSAR), molecular docking, molecular dynamics (MD) simulations, and binding free energy analysis were performed. The results showed that CoMFA (R2cv = 0.591, R2pred = 0.7698) and CoMSIA (R2cv = 0.629, R2pred = 0.6848) models possessed robust stability and predictability. The derived contour maps of steric, electrostatic, and hydrogen bond donor field further displayed the modified information of these inhibitors. Molecular docking was further conducted to provide the initial binding conformation for MD simulations. Subsequently, MD simulations were applied to explore the key amino acids and binding modes at the active site. The binding free energy decomposition analysis further indicates that the residues Ile54, Glu55, Arg83, Ala85, Val86 and Thr128 are essential for the high selectivity of inhibitors. Overall, these results would serve as a significant guideline for the discovery and design of novel GyrB inhibitors.
- Published
- 2022
- Full Text
- View/download PDF
29. Structural Insights on Hyp-Gly-Containing Peptides as Antiplatelet Compounds through Topomer CoMFA and CoMSIA Analysis
- Author
-
Yijie Yang, Qi Tian, Shiming Li, and Bo Li
- Subjects
antiplatelet ,collagen peptide ,thrombosis ,QSAR ,Topomer CoMFA ,CoMSIA ,Chemical technology ,TP1-1185 - Abstract
Increasing evidence has shown collagen hydrolysate involves a variety of bioactivities. In our previous study, multiple antiplatelet peptides containing Hyp/Pro-Gly were identified in collagen hydrolysates from Salmo salar and silver carp skin and exhibited anti-thrombosis activity without bleeding risks in vivo. However, the relationship between structure and activity remains unknown. We performed 3D-QSAR studies on 23 Hyp/Pro-Gly-containing peptides in which 13 peptides were reported before. CoMFA, Topomer CoMFA and CoMSIA analyses were used to generate the QSAR models. Topomer CoMFA analysis showed a q2 value of 0.710, an r2 value of 0.826, an r2pred value of 0.930, and the results showed that Hyp instead of Pro was more important for improving the antiplatelet activity. CoMSIA analysis showed a q2 value of 0.461, an r2 value of 0.999, and an r2pred value of 0.999. Compared with the electrostatic field and hydrogen bond donor field, the steric field, hydrophobic field and hydrogen bond receptor field have great influence on the activity of antiplatelet peptides. The predicted peptide EOGE exhibited antiplatelet activity induced by ADP, and inhibited thrombus formation (300 μmol/kg bw) without bleeding risks. Combined results of these studies indicate that OG-containing peptides had a potential to be developed into an effective specific medical food in the prevention of thrombotic diseases.
- Published
- 2023
- Full Text
- View/download PDF
30. Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia.
- Author
-
Rathore, Akash, Asati, Vivek, Mishra, Mitali, Das, Ratnesh, Kashaw, Varsha, and Kashaw, Sushil Kumar
- Subjects
- *
DOPAMINE antagonists , *DOPAMINE receptors , *PIPERAZINE , *SEROTONIN receptors , *COMPARATIVE molecular field analysis , *DOPAMINE , *MOLECULAR docking , *PIPERIDINE - Abstract
Piperidine and piperazine derivatives exhibit a diverse range of biological applications, including antipsychotic activity. In this study, a dataset of molecules containing piperidine, piperazine moieties that possess serotonin 5-HT2A and dopamine D2 inhibitory activity have been chosen for Pharmacophore modeling, Quantitative Structure–Activity (3D-QSAR) Relationship, Molecular docking, and ADME studies. The pharmacophoric hypothesis was found to be AAHPRRR_1 having seven features as one H-bond acceptor (A), one hydrophobic (H), one positive ion acceptor (P), and three aromatic rings (R), with survival score = 6.465 and AUC = 0.92. Based on the best hypothesis, the ZINC-Data base was virtually screened to find out the lead molecules. 3D-QSAR model, including internal and external validation showed comparative molecular field analysis (CoMFA) against 5HT2A (q2 = 0.552, R2 = 0.889, and r2 poured. = 0.653 and number of component 5) and comparative molecular similarity indices analysis (CoMSIA) (q2 = 0.599, R2 = 0.893, and r2 pred. = 0.617), for D2 (CoMFA, q2 = 0.577, R2 = 0.863, and r2 pred. = 0.598) (CoMSIA, q2 = 0.532, R2 = 0.82) all results exhibited better productivity and significant statistical reliability of the model. The docking study was carried out on the crystal structure of 5-HT2A having PDB ID; 6A93 and D2 receptor having PDB ID; 6CM4. The screened compound ZINC74289318 possess a higher docking score − 10.744 and − 11.388 than co-crystallized ligand docking score − 8.840 and − 10.06 against 5-HT2A and D2 receptor respectively. Further, ZINC74289318 was screened for all drug-likeness parameters and no showed violation of the Lipinski rule of five. Also, it was found to possess good bioavailability of 0.55 with synthetic accessibility of 4.42 which is greater than risperidone. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Structural Insights from Molecular Modeling of Isoindolin-1-One Derivatives as PI3Kγ Inhibitors against Gastric Carcinoma.
- Author
-
Ghosh, Suparna and Cho, Seung Joo
- Subjects
STOMACH cancer ,TUMOR necrosis factors ,COMPARATIVE molecular field analysis ,STRUCTURE-activity relationships ,BINDING energy - Abstract
The upregulation of phosphoinositol-3-kinase γ (PI3Kγ) is deemed to be positively correlated with tumor-associated-macrophage (TAM)-mediated gastric carcinoma (GC). PI3Kγ suppresses tumor necrosis factor-alpha (TNF-α) and interleukin-12 (IL-12) through activation of the AKT/mTOR pathway, which promotes the immunosuppressant phenotype of TAM. Unlike α and β isoforms, δ and γ isoforms are primarily distributed in leucocytes and macrophages. Dual inhibitors against PI3Kδ and PI3Kγ have been proven to have merits in targeting solid tumors. Furthermore, it has been found that PI3Kδ is activated by cytokines, while PI3Kγ is activated by G-protein-coupled receptors (GPCRs). This facilitates determining the functional difference between these two isoforms. For this goal, selective inhibitors would be immensely helpful. In the current manuscript, we conducted various molecular modeling studies with a series of isoindolin-1-one derivatives as potent PI3Kγ inhibitors by combining molecular docking, molecular dynamics (MD), molecular mechanics, Poisson–Boltzmann/generalized Born surface area (MM-PB/GBSA) binding free energy calculation, and three-dimensional structure–activity relationship (3D-QSAR) study. To evaluate the selectivity of γ isoform over δ, the molecular modeling studies of idelalisib analogs reported as PI3Kδ inhibitors were also investigated. The contour polyhedrons were generated from the comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA) around the ligand-bound active site for both isoforms, which could emphasize plausible explanations for the physicochemical factors that affect selective ligand recognition. The binding modalities of the two isoforms using CoMFA and MD models were compared, which suggested some key differences in the molecular interactions with the ligands and could be summarized as three subsites (one affinity subsite near the C-helix and DFG and two hydrophobic subsites). In the context of the structure–activity relationship (SAR), several new compounds were designed using a fragment-substitution strategy with the aim of selectively targeting PI3Kγ. The pIC
50 values of the designed compounds were predicted by the 3D-QSAR models, followed by the MM-PB/GBSA binding energy estimation. The overall findings suggest that the designed compounds have the potential to be used as PI3Kγ inhibitors with a higher binding affinity and selectivity. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
32. Applying comparative molecular modelling techniques on diverse hydroxamate-based HDAC2 inhibitors: an attempt to identify promising structural features for potent HDAC2 inhibition.
- Author
-
Yadav, V., Banerjee, S., Baidya, S.K., Adhikari, N., and Jha, T.
- Subjects
- *
HISTONE deacetylase inhibitors , *DRUG development , *THERAPEUTICS , *NEURODEGENERATION , *MOIETIES (Chemistry) - Abstract
Histone deacetylase 2 (HDAC2) has been implicated in a variety of cardiovascular and neurodegenerative disorders as well as in cancers. Thus, HDAC2 has become an exclusive target for anticancer drug development. Therefore, the development of newer HDAC2 inhibitors in disease conditions is a prime goal to restrain such a scenario. Although a handful of HDAC inhibitors was accepted for the treatment of HDAC-related disease conditions, the non-selective nature of these entities is one of the major setbacks in the treatment of specific HDAC isoform-related pathophysiology. In this framework, the analyses of pre-existing molecules are essential to identify the important structural features that can fulfil the requirements for the cap and linker moieties to obtain potent and effective HDAC2 inhibition. Thus, in this study, the implementation of a combined comparative 2D and 3D molecular modelling techniques was done on a group of 92 diverse hydroxamate derivatives having a wide range of HDAC2 inhibitory potency. Besides other crucial features, this study upheld the importance of groups like triazole and benzyl moieties along with the molecular fields that are crucial for regulating HDAC2 inhibition. The outcomes of this study may be employed for the designing of HDAC2 inhibitors in future. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
33. 3D-QSAR, Molecular Docking, and MD Simulations of Anthraquinone Derivatives as PGAM1 Inhibitors.
- Author
-
Wang, Yuwei, Guo, Yifan, Qiang, Shaojia, Jin, Ruyi, Li, Zhi, Tang, Yuping, Leung, Elaine Lai Han, Guo, Hui, and Yao, Xiaojun
- Subjects
ANTHRAQUINONE derivatives ,MOLECULAR docking ,COMPARATIVE molecular field analysis ,ANTHRAQUINONES ,EMODIN ,STRUCTURE-activity relationships ,CANCER cell proliferation - Abstract
PGAM1 is overexpressed in a wide range of cancers, thereby promoting cancer cell proliferation and tumor growth, so it is gradually becoming an attractive target. Recently, a series of inhibitors with various structures targeting PGAM1 have been reported, particularly anthraquinone derivatives. In present study, the structure–activity relationships and binding mode of a series of anthraquinone derivatives were probed using three-dimensional quantitative structure–activity relationships (3D-QSAR), molecular docking, and molecular dynamics (MD) simulations. Comparative molecular field analysis (CoMFA, r
2 = 0.97, q2 = 0.81) and comparative molecular similarity indices analysis (CoMSIA, r2 = 0.96, q2 = 0.82) techniques were performed to produce 3D-QSAR models, which demonstrated satisfactory results, especially for the good predictive abilities. In addition, molecular dynamics (MD) simulations technology was employed to understand the key residues and the dominated interaction between PGAM1 and inhibitors. The decomposition of binding free energy indicated that the residues of F22, K100, V112, W115, and R116 play a vital role during the ligand binding process. The hydrogen bond analysis showed that R90, W115, and R116 form stable hydrogen bonds with PGAM1 inhibitors. Based on the above results, 7 anthraquinone compounds were designed and exhibited the expected predictive activity. The study explored the structure–activity relationships of anthraquinone compounds through 3D-QSAR and molecular dynamics simulations and provided theoretical guidance for the rational design of new anthraquinone derivatives as PGAM1 inhibitors. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
34. In silico design of antimicrobial oligopeptides based on 3D-QSAR modeling and bioassay evaluation.
- Author
-
Li, Guangping, Wang, Yuxuan, Shen, Yan, Guo, Haiqiong, He, Qingxiu, Hu, Yong, Liu, Haibin, Lin, Zhihua, and Wang, Yuanqiang
- Abstract
The emergence of multidrug resistance bacteria poses a great health theat. Therefore, it is a crucial demand to obtain new antibacterial drugs. Antimicrobial peptides (AMPs) have the characteristics of wide antimicrobial spectrum and lower drug resistance, hence, it is hopeful to substitute for classical antibiotics. In this study, two classic methods, comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA), were used to analyze the structural feature of AMPs against Staphylococcus aureus or Escherichia coli, respectively. Subsequently, the models established by three-dimensional quantitative structure–activity relationships (3D-QSAR) (for S. aureus, CoMFA: Q
2 = 0.512, R2 = 0.943, F = 59.916; CoMSIA: Q2 = 0.645, R2 = 0.993, F = 339.242; for E. Coli, CoMFA: Q2 = 0.507, R2 = 0.913, F = 66.862; CoMSIA: Q2 = 0.573, R2 = 0.966, F = 96.84) have good predictability and stability was constructed. Seven novel small AMPs were designed and synthesized based on the theoretical model. The novel AMPs showed potent antibacterial activity against S. aureus and E. coli while causing low host toxicity. This study provides a potential therapeutic option using 3D-QSAR models guiding the design and modification of novel AMPs, to address the prevalent infections caused by MDR bacterial. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
35. Studies on molecular mechanism between SHP2 and pyridine derivatives by 3D-QSAR, molecular docking and MD simulations
- Author
-
Fangfang Wang, Wei Yang, Zhonglin Li, and Bo Zhou
- Subjects
SHP2 ,CoMFA ,CoMSIA ,Molecular docking ,Molecular dynamics ,Chemistry ,QD1-999 - Abstract
Background: Src homology 2 (SH2)-containing protein tyrosine phosphatase 2 (SHP2) as a major phosphatase would affect the development of tumors by regulating several cellular processes, and is a significant potential target for cancer treatment. Methods: In the present work, a series of pyridine derivatives possessing a wide range of inhibitory activity was employed to investigate the structural requirements by developing three dimensional quantitative structure–activity relationship (3D-QSAR) models using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) methods. The results show that CoMFA (R2cv = 0.646, R2pred = 0.5587) and CoMSIA (R2cv = 0.777, R2pred = 0.7131) have excellent stability and predictability. The relationship between the inhibitory activity and structure of the inhibitors was analyzed by the derived contour maps. Furthermore, the QSAR models were validated by molecular docking and molecular dynamics simulations, which were also applied to reveal the potential molecular mechanism of these inhibitors. Findings: It was found that Arg110, Asn216, Thr218, Thr252 and Pro490 play a crucial role in stabilizing the inhibitors. Additionally, MM/PBSA calculations provided the binding free energy were also conducted to explain the discrepancy of binding activities. Overall, the outcomes of this work could provide useful information and theoretical guidance for the development of novel and potent SHP2 inhibitors.
- Published
- 2021
- Full Text
- View/download PDF
36. 3D-QSAR, Molecular Docking, and MD Simulations of Anthraquinone Derivatives as PGAM1 Inhibitors
- Author
-
Yuwei Wang, Yifan Guo, Shaojia Qiang, Ruyi Jin, Zhi Li, Yuping Tang, Elaine Lai Han Leung, Hui Guo, and Xiaojun Yao
- Subjects
PGAM1 ,molecular docking ,molecular dynamics simulation ,CoMFA ,CoMSIA ,Therapeutics. Pharmacology ,RM1-950 - Abstract
PGAM1 is overexpressed in a wide range of cancers, thereby promoting cancer cell proliferation and tumor growth, so it is gradually becoming an attractive target. Recently, a series of inhibitors with various structures targeting PGAM1 have been reported, particularly anthraquinone derivatives. In present study, the structure–activity relationships and binding mode of a series of anthraquinone derivatives were probed using three-dimensional quantitative structure–activity relationships (3D-QSAR), molecular docking, and molecular dynamics (MD) simulations. Comparative molecular field analysis (CoMFA, r2 = 0.97, q2 = 0.81) and comparative molecular similarity indices analysis (CoMSIA, r2 = 0.96, q2 = 0.82) techniques were performed to produce 3D-QSAR models, which demonstrated satisfactory results, especially for the good predictive abilities. In addition, molecular dynamics (MD) simulations technology was employed to understand the key residues and the dominated interaction between PGAM1 and inhibitors. The decomposition of binding free energy indicated that the residues of F22, K100, V112, W115, and R116 play a vital role during the ligand binding process. The hydrogen bond analysis showed that R90, W115, and R116 form stable hydrogen bonds with PGAM1 inhibitors. Based on the above results, 7 anthraquinone compounds were designed and exhibited the expected predictive activity. The study explored the structure–activity relationships of anthraquinone compounds through 3D-QSAR and molecular dynamics simulations and provided theoretical guidance for the rational design of new anthraquinone derivatives as PGAM1 inhibitors.
- Published
- 2021
- Full Text
- View/download PDF
37. Structure-Activity Relationship Studies Based on 3D-QSAR CoMFA/CoMSIA for Thieno-Pyrimidine Derivatives as Triple Negative Breast Cancer Inhibitors
- Author
-
Jin-Hee Kim and Jin-Hyun Jeong
- Subjects
TNBC ,VEGFR3 ,thieno-pyrimidine derivatives ,3D-QSAR ,CoMFA ,CoMSIA ,Organic chemistry ,QD241-441 - Abstract
Triple-negative breast cancer (TNBC) is defined as a kind of breast cancer that lacks estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptors (HER2). This cancer accounts for 10–15% of all breast cancers and has the features of high invasiveness and metastatic potential. The treatment regimens are still lacking and need to develop novel inhibitors for therapeutic strategies. Three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses, based on a series of forty-seven thieno-pyrimidine derivatives, were performed to identify the key structural features for the inhibitory biological activities. The established comparative molecular field analysis (CoMFA) presented a leave-one-out cross-validated correlation coefficient q2 of 0.818 and a determination coefficient r2 of 0.917. In comparative molecular similarity indices analysis (CoMSIA), a q2 of 0.801 and an r2 of 0.897 were exhibited. The predictive capability of these models was confirmed by using external validation and was further validated by the progressive scrambling stability test. From these results of validation, the models were determined to be statistically reliable and robust. This study could provide valuable information for further optimization and design of novel inhibitors against metastatic breast cancer.
- Published
- 2022
- Full Text
- View/download PDF
38. HQSAR, CoMFA, CoMSIA Docking Studies and Simulation MD on Quinazolines/Quinolines Derivatives for DENV Virus Inhibitory Activity
- Author
-
Tabti, Kamal, Elmchichi, Larbi, Sbai, Abdelouahid, Maghat, Hamid, Bouachrine, Mohammed, and Lakhlifi, Tahar
- Published
- 2022
- Full Text
- View/download PDF
39. Effects of 1,4-dihydropyridine derivatives on cell injury and mTOR of HepG2 and 3D-QSAR study.
- Author
-
Liu, Huan, Zhu, Siyu, Xia, Guiqiong, Huang, Zhuoquan, Han, Wenna, Li, Zhongyi, and Liu, Chunhong
- Subjects
- *
MTOR protein , *CYTOTOXINS , *CELL survival , *CONTOURS (Cartography) , *WOUNDS & injuries , *BIOPROSPECTING , *HARM (Ethics) - Abstract
1,4-dihydropyridine derivatives (1,4-DHPs) are a class of drugs used to treat cardiovascular diseases, but these drugs can cause liver injury. To reveal the toxicity characteristics of these compounds, we used a series of assays, including cell viability, enzyme activity detection, and western blotting, to investigate the toxicity of seven kinds of 1,4-DHPs (0–100 μM) on HepG2 cells and establish 3D-QSAR model based on relevant toxicity data. After HepG2 cells were treated with 1,4-DHPs for 24 h, high-dose (100 μM) 1,4-DHPs decreased cell viability to varying degrees, while ROS and MDA contents were significantly increased, and ATP content was reduced. Moreover, with the concentration of 100 μM 1,4-DHPs (Nimodipine, Nitrendipine, Cilnidipine, and Manidipine) were markedly inhibited the phosphorylation levels of mTOR protein. The results of the 3D-QSAR model showed that the non-cross validation coefficient (R2) and cross validation coefficient (Q2) of the model were 0.982 and 0.652, respectively. Combined with external validation and the Williams diagram, the model showed good predictability and application domain. Based on the CoMSIA 3D contour map, the introduction of large volume and hydrogen bond receptor groups on the carbonyl oxygen side chains of the 1,4-DHPs ring 3- and 5- was beneficial for reducing the toxicity of 1,4-DHPs. The results of this study could supplement information on the cytotoxicity of 1,4-DHPs, and could provide theoretical support for predicting the toxicity of 1,4-DHPs. [Display omitted] • The model of 1,4-DHPs toxicity prediction is established by cytotoxicity test. • The method is used to predict the toxicity of 1,4-DHPs. • The model is built by the CoMSIA with good stability and predictive ability. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR Approach
- Author
-
Swapnil P. Bhujbal and Jung-Mi Hah
- Subjects
chemotherapy ,cancer ,CD73 ,molecular docking ,CoMFA ,CoMSIA ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Radiotherapy and chemotherapy are conventional cancer treatments. Around 60% of all patients who are diagnosed with cancer receive radio- or chemotherapy in combination with surgery during their disease. Only a few patients respond to the blockage of immune checkpoints alone, or in combination therapy, because their tumours might not be immunogenic. Under these circumstances, an increasing level of extracellular adenosine via the activation of ecto-5’-nucleotidase (CD73) and consequent adenosine receptor signalling is a typical mechanism that tumours use to evade immune surveillance. CD73 is responsible for the conversion of adenosine monophosphate to adenosine. CD73 is overexpressed in various tumour types. Hence, targetting CD73’s signalling is important for the reversal of adenosine-facilitated immune suppression. In this study, we selected a potent series of the non-nucleotide small molecule inhibitors of CD73. Molecular docking studies were performed in order to examine the binding mode of the inhibitors inside the active site of CD73 and 3D-QSAR was used to study the structure–activity relationship. The obtained CoMFA (q2 = 0.844, ONC = 5, r2 = 0.947) and CoMSIA (q2 = 0.804, ONC = 4, r2 = 0.954) models showed reasonable statistical values. The 3D-QSAR contour map analysis revealed useful structural characteristics that were needed to modify non-nucleotide small molecule inhibitors. We used the structural information from the overall docking and 3D-QSAR results to design new, potent CD73 non-nucleotide inhibitors. The newly designed CD73 inhibitors exhibited higher activity (predicted pIC50) than the most active compound of all of the derivatives that were selected for this study. Further experimental studies are needed in order to validate the new CD73 inhibitors.
- Published
- 2021
- Full Text
- View/download PDF
41. Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia
- Author
-
Rathore, Akash, Asati, Vivek, Mishra, Mitali, Das, Ratnesh, Kashaw, Varsha, and Kashaw, Sushil Kumar
- Published
- 2022
- Full Text
- View/download PDF
42. 3D-QSAR Studies on High-affinity Phosphodiestera.
- Author
-
Shi L and Si H
- Abstract
Background: Recent studies have found that Phosphodiesterase-4 (PDE4) is closely related to the pathogenesis of depression, cognitive impairment and neurological impairment., Objective: Our objective is to develop potent inhibitors of the high-affinity phosphodiesterase 4D isoform (PDE4D) that can serve as radioligands for Positron Emission Tomography (PET) imaging, thereby advancing research in the field of neurological diseases., Methods: We employed a multi-step approach combining three-dimensional quantitative structure-activity relationship (3D-QSAR) modeling, molecular docking, classification techniques, and CoMSIA analysis to investigate the conformational relationship of highaffinity PDE4D inhibitors as PET ligands. ADMET and Drug-likeness predictions were also conducted. By utilizing these methods, our aim was to identify more potent PDE4D inhibitors., Results: The results showed that the CoMSIA model with the best principal component scores (n=7) had a cross-validated Q2 value of 0.602 and a non-cross-validated R2 value of 0.976. These results affirmed the excellent predictive capability of the established CoMSIA model. Analysis of the generated 3D-QSAR contour plots highlighted specific regions in the molecular structure of the compounds that can be further optimized and modified. Guided by the contour plots, we designed 100 novel PDE4D inhibitors, and molecular docking was performed for the top 4 compounds with high activity. The molecular docking scores were promising, and ADMET and drug similarity predictions yielded satisfactory results. Taking into consideration these factors, compound 51c was determined to be the optimal compound, laying a solid foundation for further research., Conclusion: For the continued development of PDE4D PET radioligand, these models and new compounds' developing methodology offer a theoretical foundation and crucial references., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2024
- Full Text
- View/download PDF
43. Structural Insights from Molecular Modeling of Isoindolin-1-One Derivatives as PI3Kγ Inhibitors against Gastric Carcinoma
- Author
-
Suparna Ghosh and Seung Joo Cho
- Subjects
Medicine (miscellaneous) ,gastric carcinoma ,PI3Kγ ,PI3Kδ ,tumor-associated macrophage ,MM-PB/GBSA ,CoMFA ,CoMSIA ,structure–activity relationship ,General Biochemistry, Genetics and Molecular Biology - Abstract
The upregulation of phosphoinositol-3-kinase γ (PI3Kγ) is deemed to be positively correlated with tumor-associated-macrophage (TAM)-mediated gastric carcinoma (GC). PI3Kγ suppresses tumor necrosis factor-alpha (TNF-α) and interleukin-12 (IL-12) through activation of the AKT/mTOR pathway, which promotes the immunosuppressant phenotype of TAM. Unlike α and β isoforms, δ and γ isoforms are primarily distributed in leucocytes and macrophages. Dual inhibitors against PI3Kδ and PI3Kγ have been proven to have merits in targeting solid tumors. Furthermore, it has been found that PI3Kδ is activated by cytokines, while PI3Kγ is activated by G-protein-coupled receptors (GPCRs). This facilitates determining the functional difference between these two isoforms. For this goal, selective inhibitors would be immensely helpful. In the current manuscript, we conducted various molecular modeling studies with a series of isoindolin-1-one derivatives as potent PI3Kγ inhibitors by combining molecular docking, molecular dynamics (MD), molecular mechanics, Poisson–Boltzmann/generalized Born surface area (MM-PB/GBSA) binding free energy calculation, and three-dimensional structure–activity relationship (3D-QSAR) study. To evaluate the selectivity of γ isoform over δ, the molecular modeling studies of idelalisib analogs reported as PI3Kδ inhibitors were also investigated. The contour polyhedrons were generated from the comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA) around the ligand-bound active site for both isoforms, which could emphasize plausible explanations for the physicochemical factors that affect selective ligand recognition. The binding modalities of the two isoforms using CoMFA and MD models were compared, which suggested some key differences in the molecular interactions with the ligands and could be summarized as three subsites (one affinity subsite near the C-helix and DFG and two hydrophobic subsites). In the context of the structure–activity relationship (SAR), several new compounds were designed using a fragment-substitution strategy with the aim of selectively targeting PI3Kγ. The pIC50 values of the designed compounds were predicted by the 3D-QSAR models, followed by the MM-PB/GBSA binding energy estimation. The overall findings suggest that the designed compounds have the potential to be used as PI3Kγ inhibitors with a higher binding affinity and selectivity.
- Published
- 2022
44. Design, Synthesis, Analysis, Evaluation of Cytotoxicity Against MCF-7 Breast Cancer Cells, 3D QSAR Studies and EGFR, HER2 Inhibition Studies on Novel Biginelli 1,4-Dihydropyrimidines.
- Author
-
Naishima, Namburu Lalitha, Faizan, Syed, Raju, Ruby Mariam, Sruthi, Aki Satya Venkata Lakshmi, NG, Veena, Sharma, Gyanedra Kumar, Vasanth, Kumar S, Shivaraju, Vasanth Kumar, Ramu, Ramith, and Kumar, BR Prashantha
- Subjects
- *
CANCER cells , *STRUCTURE-activity relationships , *BREAST cancer , *EPIDERMAL growth factor receptors , *ANTINEOPLASTIC agents - Abstract
• 1,4-Dihydropyrimidines are usually synthesized from Biginelli reaction. • A series of novel Biginelli-1,4-dihydropyrimidines are rationally designed and synthesized. • Screened against MCF-7 breast cancer cells for their anti-cancer activity by measuring the cytotoxicity. • Dihydropyrimidines exhibited weak to significant cytotoxicity. • Most potent compound (compound 14) is found to inhibit EGFR and HER2 • 3D-QSAR studies were executed to elucidate structure activity relationships in a 3D grid space. • Identified compound 14 to investigate further for its anticancer activity. 1,4-Dihydropyrimidines are usually synthesized from Biginelli reaction which are well known for their anti-cancer activity. A series of novel Biginelli-1,4-dihydropyrimidines are rationally designed, synthesized, purified, analyzed by IR, NMR, Mass spectrometry and screened against MCF-7 breast cancer cells for their anti-cancer activity by measuring the cytotoxicity. Dihydropyrimidines exhibited weak to significant cytotoxicity proportionate to their anti-cancer activity. 14, 7 and 5 have exhibited potent cytotoxicity amongst the screened 33 dihydropyrimidines. Most potent compound 14 is further tested for inhibition of EGFR (epidermal growth factor receptor) and HER2 (human epidermal growth factor receptor 2) expression at 2 different concentrations by taking lapatinib as standard in flow cytometry. 42.02% and 36.45% of cells expressing EGFR and HER2 were inhibited at 500nM/L concentration. Furthermore, 3D-QSAR studies were executed to elucidate structure activity relationships in a 3D grid space by plotting experimental vs predicted cytotoxic activities. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. Molecular Modeling Studies of N-phenylpyrimidine-4-amine Derivatives for Inhibiting FMS-like Tyrosine Kinase-3
- Author
-
Seung Joo Cho, Suparna Ghosh, and Seketoulie Keretsu
- Subjects
CoMFA ,Molecular model ,Stereochemistry ,QH301-705.5 ,acute myeloid leukemia ,Molecular mechanics ,Catalysis ,Inorganic Chemistry ,Molecular dynamics ,Physical and Theoretical Chemistry ,Tyrosine ,Biology (General) ,Molecular Biology ,QD1-999 ,Spectroscopy ,binding free energy ,3D-QSAR ,biology ,Chemistry ,Organic Chemistry ,Active site ,MD simulation ,General Medicine ,Ligand (biochemistry) ,Computer Science Applications ,Docking (molecular) ,FMS-like tyrosine kinase-3 ,Fms-Like Tyrosine Kinase 3 ,biology.protein ,CoMSIA - Abstract
Overexpression and frequent mutations in FMS-like tyrosine kinase-3 (FLT3) are considered risk factors for severe acute myeloid leukemia (AML). Hyperactive FLT3 induces premature activation of multiple intracellular signaling pathways, resulting in cell proliferation and anti-apoptosis. We conducted the computational modeling studies of 40 pyrimidine-4,6-diamine-based compounds by integrating docking, molecular dynamics, and three-dimensional structure–activity relationship (3D-QSAR). Molecular docking showed that K644, C694, F691, E692, N701, D829, and F830 are critical residues for the binding of ligands at the hydrophobic active site. Molecular dynamics (MD), together with Molecular Mechanics Poison–Boltzmann/Generalized Born Surface Area, i.e., MM-PB(GB)SA, and linear interaction energy (LIE) estimation, provided critical information on the stability and binding affinity of the selected docked compounds. The MD study suggested that the mutation in the gatekeeper residue F691 exhibited a lower binding affinity to the ligand. Although, the mutation in D835 in the activation loop did not exhibit any significant change in the binding energy to the most active compound. We developed the ligand-based comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA) models. CoMFA (q2 = 0.802, r2 = 0.983, and QF32 = 0.698) and CoMSIA (q2 = 0.725, r2 = 0.965 and QF32 = 0.668) established the structure–activity relationship (SAR) and showed a reasonable external predictive power. The contour maps from the CoMFA and CoMSIA models could explain valuable information about the favorable and unfavorable positions for chemical group substitution, which can increase or decrease the inhibitory activity of the compounds. In addition, we designed 30 novel compounds, and their predicted pIC50 values were assessed with the CoMSIA model, followed by the assessment of their physicochemical properties, bioavailability, and free energy calculation. The overall outcome could provide valuable information for designing and synthesizing more potent FLT3 inhibitors.
- Published
- 2021
- Full Text
- View/download PDF
46. Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR Approach
- Author
-
Jung-Mi Hah and Swapnil P. Bhujbal
- Subjects
Models, Molecular ,Adenosine monophosphate ,Quantitative structure–activity relationship ,CoMFA ,Combination therapy ,QH301-705.5 ,chemotherapy ,cancer ,CD73 ,molecular docking ,CoMSIA ,3D-QSAR ,inhibitors ,Quantitative Structure-Activity Relationship ,GPI-Linked Proteins ,Article ,Catalysis ,Inorganic Chemistry ,chemistry.chemical_compound ,Catalytic Domain ,medicine ,Humans ,Computer Simulation ,Enzyme Inhibitors ,Physical and Theoretical Chemistry ,Biology (General) ,5'-Nucleotidase ,Molecular Biology ,QD1-999 ,Spectroscopy ,Binding Sites ,Molecular Structure ,Organic Chemistry ,Cancer ,General Medicine ,medicine.disease ,Small molecule ,Adenosine receptor ,Adenosine ,Computer Science Applications ,Molecular Docking Simulation ,Chemistry ,chemistry ,Docking (molecular) ,Cancer research ,Protein Binding ,medicine.drug - Abstract
Radiotherapy and chemotherapy are conventional cancer treatments. Around 60% of all patients who are diagnosed with cancer receive radio- or chemotherapy in combination with surgery during their disease. Only a few patients respond to the blockage of immune checkpoints alone, or in combination therapy, because their tumours might not be immunogenic. Under these circumstances, an increasing level of extracellular adenosine via the activation of ecto-5’-nucleotidase (CD73) and consequent adenosine receptor signalling is a typical mechanism that tumours use to evade immune surveillance. CD73 is responsible for the conversion of adenosine monophosphate to adenosine. CD73 is overexpressed in various tumour types. Hence, targetting CD73’s signalling is important for the reversal of adenosine-facilitated immune suppression. In this study, we selected a potent series of the non-nucleotide small molecule inhibitors of CD73. Molecular docking studies were performed in order to examine the binding mode of the inhibitors inside the active site of CD73 and 3D-QSAR was used to study the structure–activity relationship. The obtained CoMFA (q2 = 0.844, ONC = 5, r2 = 0.947) and CoMSIA (q2 = 0.804, ONC = 4, r2 = 0.954) models showed reasonable statistical values. The 3D-QSAR contour map analysis revealed useful structural characteristics that were needed to modify non-nucleotide small molecule inhibitors. We used the structural information from the overall docking and 3D-QSAR results to design new, potent CD73 non-nucleotide inhibitors. The newly designed CD73 inhibitors exhibited higher activity (predicted pIC50) than the most active compound of all of the derivatives that were selected for this study. Further experimental studies are needed in order to validate the new CD73 inhibitors.
- Published
- 2021
47. Molecular Modeling Studies of
- Author
-
Suparna, Ghosh, Seketoulie, Keretsu, and Seung Joo, Cho
- Subjects
Binding Sites ,CoMFA ,Quantitative Structure-Activity Relationship ,MD simulation ,Molecular Dynamics Simulation ,acute myeloid leukemia ,Ligands ,Article ,Molecular Docking Simulation ,Leukemia, Myeloid, Acute ,Structure-Activity Relationship ,Pyrimidines ,fms-Like Tyrosine Kinase 3 ,Catalytic Domain ,FMS-like tyrosine kinase-3 ,Humans ,Computer Simulation ,Amines ,Protein Kinase Inhibitors ,Signal Transduction ,binding free energy ,3D-QSAR ,CoMSIA - Abstract
Overexpression and frequent mutations in FMS-like tyrosine kinase-3 (FLT3) are considered risk factors for severe acute myeloid leukemia (AML). Hyperactive FLT3 induces premature activation of multiple intracellular signaling pathways, resulting in cell proliferation and anti-apoptosis. We conducted the computational modeling studies of 40 pyrimidine-4,6-diamine-based compounds by integrating docking, molecular dynamics, and three-dimensional structure–activity relationship (3D-QSAR). Molecular docking showed that K644, C694, F691, E692, N701, D829, and F830 are critical residues for the binding of ligands at the hydrophobic active site. Molecular dynamics (MD), together with Molecular Mechanics Poison–Boltzmann/Generalized Born Surface Area, i.e., MM-PB(GB)SA, and linear interaction energy (LIE) estimation, provided critical information on the stability and binding affinity of the selected docked compounds. The MD study suggested that the mutation in the gatekeeper residue F691 exhibited a lower binding affinity to the ligand. Although, the mutation in D835 in the activation loop did not exhibit any significant change in the binding energy to the most active compound. We developed the ligand-based comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA) models. CoMFA (q2 = 0.802, r2 = 0.983, and QF32 = 0.698) and CoMSIA (q2 = 0.725, r2 = 0.965 and QF32 = 0.668) established the structure–activity relationship (SAR) and showed a reasonable external predictive power. The contour maps from the CoMFA and CoMSIA models could explain valuable information about the favorable and unfavorable positions for chemical group substitution, which can increase or decrease the inhibitory activity of the compounds. In addition, we designed 30 novel compounds, and their predicted pIC50 values were assessed with the CoMSIA model, followed by the assessment of their physicochemical properties, bioavailability, and free energy calculation. The overall outcome could provide valuable information for designing and synthesizing more potent FLT3 inhibitors.
- Published
- 2021
48. 3D-QSAR modeling and molecular docking studies on a series of 2, 4, 5-trisubstituted imidazole derivatives as CK2 inhibitors.
- Author
-
Goudzal A, El Aissouq A, El Hamdani H, Hadaji EG, Ouammou A, and Bouachrine M
- Subjects
- Molecular Docking Simulation, Models, Molecular, Quantitative Structure-Activity Relationship, Imidazoles pharmacology, Antineoplastic Agents chemistry, Nitroimidazoles
- Abstract
Protein case in kinase II alpha subunit (CK2) plays an imperative function in treating cancer disease. Herein, we have performed a three-dimensional quantitative structure activity relationship (3D-QSAR), and molecular docking analysis on a novel series of 2, 4, 5-trisubstituted imidazole derivatives in order to design potent kinase II alpha subunit (CK2) inhibitors. The 3D-QSAR methods such as comparative molecular similarity indexes analysis (COMSIA), and the comparative molecular field analysis (COMFA) were investigate using twenty-four molecules of 2, 4, 5-trisubstituted imidazole derivatives as anticancer agent. The best COMFA and COMSIA models exhibit excellent Q 2 values of 0.66 and 0.75 and R 2 values of 0.98 and 0.99 respectively. To check the validity of the selected COMFA and COMSIA models, a variety of validation tests were utilized: Internal validation analyses, and externally validation beside Y-randomization according to the principles of the Organization for Economic Co-operation and Development (OECD), and the Golbraikh and Tropsha's criteria for the validation of 3D-QSAR models. The proposed models for COMFA and COMSIA analysis have been successful. The developed models, indicating that they were reliable for activity prediction. Based on the preceding results, we designed several new potent molecules. Such outcome can proffer helpful theoretical references for future experimental studies.Communicated by Ramaswamy H. Sarma.
- Published
- 2023
- Full Text
- View/download PDF
49. Tit Structure-activity Relationship Study and Design of Novel 1, 8- Naphthimide Derivatives as Potential DNA-targeting Chemotherapeutic Agents for Osteosarcoma.
- Author
-
Lian Z, Si H, Xia H, and Zhai H
- Subjects
- Humans, Molecular Docking Simulation, Quantitative Structure-Activity Relationship, Software, Drug Design, Antineoplastic Agents pharmacology, Antineoplastic Agents chemistry, Neoplasms
- Abstract
Background: 1, 8-naphthimide is a novel tumor inhibitor targeting nuclear DNA, which makes it applicable to the design and development of anti-osteosarcoma drugs., Objective: The aim of this study is to establish a satisfactory model based on 1, 8-naphthimide derivatives that makes reliable prediction as DNA-targeted chemotherapy agents for osteosarcoma., Methods: All compounds are constructed using ChemDraw software and subsequently optimized using Sybyl software. COMSIA method is used to construct QSAR model with the optimized compound in Sybyl software package. A series of new 1, 8-naphthalimide derivatives are designed and their IC
50 values are predicted using the QSAR model. Finally, the newly designed compounds are screened according to IC50 values, and molecular docking experiments are conducted on the top ten compounds of IC50 ., Results: The COMSIA model shows that q2 is 0.529 and the optimum number of components is 6. The model has a high r2 value of 0.993 and a low SEE of 0.033, with the F value and the r2 predicted to be 495.841 and 0.996 respectively. The statistical results and verification results of the model are satisfactory. In addition, analyzing the contour maps is conducive to finding the structural requirements., Conclusion: The results of this study can provide guidance for medical chemists and other related workers to develop targeted chemotherapy drugs for osteosarcoma., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)- Published
- 2023
- Full Text
- View/download PDF
50. Studies on the antibacterial activities and molecular mechanism of GyrB inhibitors by 3D-QSAR, molecular docking and molecular dynamics simulation.
- Author
-
Wang, Fangfang, Yang, Wei, and Zhou, Bo
- Abstract
DNA gyrase B (GyrB) plays a critical role in DNA replication, repair, recombination, and transcription and has become an attractive target for a number of antibacterial agents. In the present work, to better comprehend the structure–activity relationship and mechanism of action of novel series of GyrB inhibitors, a theoretical study of three-dimensional-quantitative structure–activity relationship (3D-QSAR), molecular docking, molecular dynamics (MD) simulations, and binding free energy analysis were performed. The results showed that CoMFA (R
2 cv = 0.591, R2 pred = 0.7698) and CoMSIA (R2 cv = 0.629, R2 pred = 0.6848) models possessed robust stability and predictability. The derived contour maps of steric, electrostatic, and hydrogen bond donor field further displayed the modified information of these inhibitors. Molecular docking was further conducted to provide the initial binding conformation for MD simulations. Subsequently, MD simulations were applied to explore the key amino acids and binding modes at the active site. The binding free energy decomposition analysis further indicates that the residues Ile54, Glu55, Arg83, Ala85, Val86 and Thr128 are essential for the high selectivity of inhibitors. Overall, these results would serve as a significant guideline for the discovery and design of novel GyrB inhibitors. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.